US Stock MarketDetailed Quotes

INRX Intrinsic Medicine

Watchlist
  • 0.000
  • 0.0000.00%
Close May 3 09:30 ET
0Market Cap0.00P/E (TTM)

Intrinsic Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Assets
Current assets
Cash, cash equivalents and short term investments
238.29%2.77M
--820K
-Cash and cash equivalents
238.29%2.77M
--820K
Prepaid assets
478.79%191K
--33K
Total current assets
247.60%2.97M
--853K
Non current assets
Non current deferred assets
--798K
--0
Total non current assets
--798K
--0
Total assets
341.15%3.76M
--853K
Liabilities
Current liabilities
Payables
350.00%135K
--30K
-accounts payable
350.00%135K
--30K
Current accrued expenses
1,304.76%1.18M
--84K
Current debt and capital lease obligation
15.08%1.5M
--1.3M
-Current debt
15.08%1.5M
--1.3M
Other current liabilities
--51K
----
Current liabilities
102.40%2.86M
--1.41M
Non current liabilities
Long term debt and capital lease obligation
--3.91M
----
-Long term debt
--3.91M
----
Derivative product liabilities
517.94%10.92M
--1.77M
Other non current liabilities
--72K
----
Total non current liabilities
743.52%14.91M
--1.77M
Total liabilities
458.54%17.77M
--3.18M
Shareholders'equity
Share capital
0.00%1K
--1K
-common stock
0.00%1K
--1K
Retained earnings
-498.87%-14.35M
---2.4M
Paid-in capital
413.43%344K
--67K
Total stockholders'equity
-501.55%-14M
---2.33M
Total equity
-501.55%-14M
---2.33M
Currency Unit
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
(FY)Dec 31, 2021(FY)Dec 31, 2020
Assets
Current assets
Cash, cash equivalents and short term investments 238.29%2.77M--820K
-Cash and cash equivalents 238.29%2.77M--820K
Prepaid assets 478.79%191K--33K
Total current assets 247.60%2.97M--853K
Non current assets
Non current deferred assets --798K--0
Total non current assets --798K--0
Total assets 341.15%3.76M--853K
Liabilities
Current liabilities
Payables 350.00%135K--30K
-accounts payable 350.00%135K--30K
Current accrued expenses 1,304.76%1.18M--84K
Current debt and capital lease obligation 15.08%1.5M--1.3M
-Current debt 15.08%1.5M--1.3M
Other current liabilities --51K----
Current liabilities 102.40%2.86M--1.41M
Non current liabilities
Long term debt and capital lease obligation --3.91M----
-Long term debt --3.91M----
Derivative product liabilities 517.94%10.92M--1.77M
Other non current liabilities --72K----
Total non current liabilities 743.52%14.91M--1.77M
Total liabilities 458.54%17.77M--3.18M
Shareholders'equity
Share capital 0.00%1K--1K
-common stock 0.00%1K--1K
Retained earnings -498.87%-14.35M---2.4M
Paid-in capital 413.43%344K--67K
Total stockholders'equity -501.55%-14M---2.33M
Total equity -501.55%-14M---2.33M
Currency Unit USDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg